News Sentiment

XBRANE sentiment intelligence

Xbrane Biopharma AB (publ) news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 52 Balanced news tone 12 relevant articles
Exchange STO Sweden
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 10.80 Week of 10 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

83/100 classification confidence.

Company focus 12

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

+0.0% over one week, +0.9% over four weeks, trend active, and below fair value.

Latest direct headline Neutral

Earnings call transcript: Xbrane Q2 2026 revenue rises as shipments resume

Market Reaction

Balanced read

51/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 83/100 classification
One-week reaction 0.0% Price digesting
Trend fit Trend active 0.9% over four weeks
Fair value -88.5% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 1
Neutral 10
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 12
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
TradingView 4
marketscreener.com 2
Biostock 2
Investing.com 1
TipRanks 1
simplywall.st 1
Generics and Biosimilars Initiative 1

Event Lens

What the news is about

Classified themes
Market update 8
Earnings 3
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-12 of 12
Generics and Biosimilars Initiative Direct company coverage

Alvotech acquires Xbrane

Tone
Neutral 50/100
Event
Market update
Published
03 May 2025 08:48
Source
Generics and Biosimilars Initiative